This valuable study reports on a novel role of PD-1 in early T cell differentiation, showing that PD-1 stimulation impairs Th2 differentiation more effectively than that of Th1, with implications for ...

The global PD-1/PD-L1 inhibitors market is projected to witness remarkable growth over the next decade, with an estimated ...

When I was diagnosed with lung cancer, I didn’t want to receive chemotherapy, especially when I was a good candidate for ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

It is Transgene's second most advanced neoantigen immunotherapy programme after TG4050 for head and neck cancer, which is in ...

After several high-profile failures, including BMS’ $1.5B breakup with Agenus, anti-TIGIT therapies are generating cautious ...

After hours of company pushback, FDA's Oncologic Drugs Advisory Committee voted that the benefit of immunotherapy in low or ...

Our future directions will focus on investigating the dynamic between PD-1 and PD-L1 by using proximity ligation assays (PLA). Additionally, we aim to broaden the scope of our research by identifying ...

Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...